TELIGEN
Report
- Report Number
- 2124215-2013-00355
- Event Type
- Injury
- Date Received
- January 14, 2013
- Date of Event
- December 28, 2012
- Report Date
- July 30, 2013
- Manufacturer
- GUIDANT CRM CLONMEL IRELAND
- Product Code
- LWS
- Removal / Correction Number
- Z-0026-2014
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- DC
- Reporter Occupation
- PHYSICIAN
Narratives
AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.
THE DEVICE IS CURRENTLY UNDERGOING ANALYSIS. WHEN ADDITIONAL INFORMATION BECOMES AVAILABLE, THIS REPORT WILL BE UPDATED.
UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, A THOROUGH EVALUATION OF THE DEVICE WAS PERFORMED. MICROSCOPIC VISUAL INSPECTION FOUND NO IRREGULARITIES. THE HEADER WAS COMPLETELY INTACT. ALL LEAD IMPEDANCE MEASUREMENTS WERE GOOD. BATTERY DEPLETION WAS DUE TO COMPROMISED LOW-VOLTAGE CAPACITOR WHICH RESULTED IN A HIGH CURRENT CONDITION. IT WAS FOUND OUT THAT THE BATTERY BYPASS CAPS WERE LEAKY.
(B)(4). BOSTON SCIENTIFIC HAS ISSUED AN ADVISORY COMMUNICATION REGARDING AN OLDER SUBSET OF COGNIS/TELIGEN DEVICES THAT IS MORE SUSCEPTIBLE TO THIS ANOMALY. SPECIFICALLY, THE PERFORMANCE OF A LOW VOLTAGE CAPACITOR MAY BE COMPROMISED OVER TIME, CAUSING AN INCREASED CURRENT DRAIN THAT CAN LEAD TO PREMATURE BATTERY DEPLETION. THIS PARTICULAR DEVICE WAS INCLUDED IN THE ADVISORY POPULATION.
ADDITIONAL INFORMATION INDICATED THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) DISPLAYED A FAULT CODE FOR VOLTAGE TOO LOW FOR REMAINING LONGEVITY AND WAS STILL HAVING ISSUE WITH HIGH OUT-OF-RANGE (OOR) SHOCK LEAD IMPEDANCE MEASUREMENTS. THIS ICD WAS EXPLANTED AND HAS BEEN RETURNED FOR ANALYSIS. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS DEVICE AND NON-BSC RIGHT VENTRICULAR (RV) LEAD DISPLAYED SHOCK IMPEDANCE MEASUREMENTS IN THE LOW 60 OHMS RANGE, THEN GREATER THAN 125 OHMS. THE PATIENT WITH THIS DEVICE SYSTEM WAS BROUGHT IN FOR FURTHER REVIEW. ISOMETRIC AND POCKET MANIPULATION EXERCISES WERE PERFORMED, HOWEVER, NO NOISE WAS OBSERVED. DEFIBRILLATION THRESHOLD (DFT) TESTING AND COMMANDED SHOCKS WERE DELIVERED WITH ALL MEASUREMENTS WITHIN ACCEPTABLE LIMITS. TO DATE, NO ADVERSE PATIENT EFFECTS WERE REPORTED AS A RESULT OF THIS CLINICAL OBSERVATION.
--
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 20486 | TELIGEN | IMPLANTABLE CARDIOVERTER DEFIBRILLATOR | LWS | GUIDANT CRM CLONMEL IRELAND | E110 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 210 MO | Hospitalization| L| R | 4469| E110| 7122 |